retatrutide mechanism triple agonist gip glp-1 glucagon Demonstrated metabolic effects of GIP, and GCG agonism as mono, Retatrutide: The GLP-1/GIP/Glucagon Triple-Agonist Guide

GLP-1 receptor agonists the treatment of type 2 diabetes: state-of-the-art

Cesare Patrone, Karolinska Institutet (KI), Sweden Updates Copyright 2020 Kim, Kim and Song

10.1073/pnas.2415815121

Note: Listen to this updated July 2025 Paloma podcast that takes a deep dive into the issue of tariffs and the potential impact on your medications

Chronic kidney disease is also becoming strategically important, especially as semaglutide data and regulatory momentum support broader cardiometabolic use

GLP-1RAs vs second- or third-line glucose-lowering medications (sensitivity analysis) We conducted the first sensitivity analysis to compare GLP-1RAs with second- or third-line glucose-lowering medications